Regenacy Pharmaceuticals
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $46M
Investors
- 7
About Regenacy Pharmaceuticals
Founded in 2016 and headquartered in Waltham, US, Regenacy Pharmaceuticals focuses on advancing therapeutics for rare diseases.Regenacy Pharmaceuticals primarily concentrates on developing a range of therapies aimed at treating rare and chronic diseases. Its product pipeline includes innovative treatments that address significant medical challenges, enhancing patient outcomes and improving quality of life. Revenue is primarily generated through strategic collaborations and licensing agreements that allow for the development and commercialization of its drug candidates. The company is actively designing new therapies aimed for clinical trials in the next 12-18 months, with a focus on rare diseases. Additionally, there are plans to expand its market presence into Europe and parts of Asia by 2024, enhancing its global footprint and accessibility to its innovations.
Who invested in Regenacy Pharmaceuticals
7 investors across 2 rounds
See all investors in Regenacy Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Regenacy Pharmaceuticals
Who invested in Regenacy Pharmaceuticals?
Regenacy Pharmaceuticals has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Regenacy Pharmaceuticals raised?
Regenacy Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Regenacy Pharmaceuticals last raise money?
Regenacy Pharmaceuticals's most recent round on record is a Series B, in Jan 2022.
What does Regenacy Pharmaceuticals do?
Founded in 2016 and headquartered in Waltham, US, Regenacy Pharmaceuticals focuses on advancing therapeutics for rare diseases.
Where is Regenacy Pharmaceuticals headquartered?
Regenacy Pharmaceuticals is headquartered in Waltham, US.
Which VCs invest in companies like Regenacy Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Regenacy Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Regenacy Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.